Disc Medicine to Present at the Piper Sandler 32nd Annual Healthcare Conference

CAMBRIDGE, Mass., Nov. 23, 2020 /PRNewswire/ — Disc Medicine, a hematology company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating diseases, announced it will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference.

Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis) in hematologic diseases. Focused on the hepcidin pathway, the master regulator of iron metabolism, Disc is advancing first-in-class therapies to transform the treatment of hematologic diseases. (PRNewsfoto/Disc Medicine)

A pre-recorded presentation by John Quisel, J.D., Ph.D., Chief Executive Officer of Disc Medicine, will be available beginning on Monday, November 23 at 10:00 am Eastern Standard Time. A link to the presentation will be provided in the “News & Events” section of Disc Medicine’s website at www.discmedicine.com.

About Disc Medicine
Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis) in hematologic diseases. Currently focused on the hepcidin pathway, the master regulator of iron metabolism, Disc is developing a portfolio of first-in-class therapeutic candidates to transform the treatment of hematologic diseases. For more information, visit www.discmedicine.com.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/disc-medicine-to-present-at-the-piper-sandler-32nd-annual-healthcare-conference-301178870.html

SOURCE Disc Medicine

Source Article

Read more

Change Healthcare to Present at the Credit Suisse 29th Annual Healthcare Conference

Change Healthcare Inc. (Nasdaq: CHNG), a leading independent healthcare technology company, today announced its participation in a virtual fireside chat via webcast at the Credit Suisse 29th Annual Healthcare Conference on Wednesday, Nov. 11, 2020 at 11:00 a.m. Eastern Time.

The live webcast and more information about this event may be accessed by visiting the Events and Presentations tab at http://ir.changehealthcare.com. The webcast replay will be available approximately 48 hours after the live webcast ends and will be accessible for 90 days following the conference.

About Change Healthcare

Change Healthcare (Nasdaq: CHNG) is a leading independent healthcare technology company, focused on insights, innovation, and accelerating the transformation of the U.S. healthcare system through the power of the Change Healthcare Platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system.

Learn more at changehealthcare.com.

CHNG-IR

View source version on businesswire.com: https://www.businesswire.com/news/home/20201028005185/en/

Contacts

Evan Smith, CFA
Investor Relations
404-338-2225
[email protected]

Source Article

Read more

Biodesix Announces Data from Three Studies on Lung Nodule Diagnosis and Management to be Shared at CHEST Annual Meeting 2020

Research Evaluates Risk Classification for Patients with Lung Nodules

Biodesix, Inc. a leading data-driven diagnostic solutions company with a focus in lung disease, recently published data from three clinical studies, which found important new information on diagnosis and management of lung nodules. Data from these studies, which are being presented at the American College of Chest Physicians (CHEST) annual meeting, demonstrate the value of the Nodify Lung™ testing strategy and confirm previously reported performance of the Nodify XL2® and Nodify CDT™ tests.

Abstract #A1464/Poster #P1319: Identification of Likely Malignant Indeterminate Pulmonary Nodules by Analysis of Autoantibodies Against Lung Cancer-Associated Antigens
Authors: Kevin Doubleday, James Jett, Laura Peek, Trevor Pitcher
A retrospective analysis of the PANOPTIC study found that the blood-based Nodify CDT test accurately identified patients whose lung nodules were likely malignant, which confirms previously reported test performance. Patients identified as Nodify CDT positive may benefit from a more rapid evaluation and intervention for cancer.

Abstract #A1468/Poster #P1325: Lung Nodule Integrated Classifier Biomarker: First Data with Real-World Clinical Use
Authors: James Jett, Kerstin Pohl, Gerard Silvestri, Steven Springmeyer
A real-world clinical use study demonstrates the utility of the blood-based Nodify XL2 test for identifying patients with likely benign lung nodules by integrating the patients’ blood-based protein data with clinical risk factors, resulting in a large proportion of low to moderate risk nodules being reclassified as very low risk. Risk reclassification can reduce invasive procedures on benign nodules and ultimately lead to improved nodule management.

Abstract #A1476/Poster #P1324: Use of Two Blood-Based Biomarker Tests in Series to Reclassify Risk of Indeterminate Pulmonary Nodules
Authors: Kevin Doubleday, James Jett, Laura Peek, Trevor Pitcher, Steven Springmeyer
Data suggest that while standard risk assessment for lung cancer is imprecise, it can be improved with the blood-based Nodify Lung testing strategy. By combining the Nodify CDT and Nodify XL2 tests, patients can be more appropriately assessed for risk of malignancy to help reduce unnecessary procedures on patients with benign nodules and delays in treatment for patients with cancer.

About Biodesix
Biodesix is a leading diagnostic company with a focus in lung disease. The Company develops diagnostic tests addressing important clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix is the first company to offer six non-invasive tests for patients with diseases of the lung. Biodesix launched the SARS-CoV-2 ddPCR™ test and the Platelia SARS-CoV-2 Total Ab in response to the global pandemic and virus that impacts the lung and causes COVID-19. The blood-based Biodesix Lung Reflex® strategy for lung cancer patients integrates the GeneStrat® and VeriStrat® tests to support treatment decisions with results in 72 hours, expediting time to treatment. The blood-based Nodify Lung™ nodule risk assessment testing strategy, consisting of the Nodify XL2™ and the Nodify CDT™ tests, evaluates the risk of malignancy in incidental pulmonary nodules, enabling physicians to better triage patients to the most appropriate course of action. Biodesix also collaborates with many of the world’s leading biotechnology and pharmaceutical companies to solve complex diagnostic challenges

Read more

Annual stone crab claw harvest begins in Florida

MARATHON, Fla. (AP) — Florida’s annual stone crab claw harvest has started amid new rules aimed at protecting future stocks and concerns about demand for claws due to the COVID-19 pandemic.

New regulations, enforced by the Florida Fish and Wildlife Conservation Commission, include increasing the minimum size of a harvested claw from 2 3/4 inches (7 centimeters) to 2 7/8 inches (7.3 centimeters); reducing the harvest season by two weeks and modifying traps to have a 2 3/16-inch (5.5-centimeter) escape ring. The season started Thursday and ends May 1.

Trap modifications must be completed by the 2023-2024 season, but Gary Graves, vice president of Keys Fisheries, one of the state’s largest processors of the tasty claws, said many commercial fishermen’s traps in the Florida Keys are already compliant.

He said commercial fishermen around the state worked with FWC officials to institute the new rules to ensure future harvests.


“We’re in favor of this (new regulations) to rebuild the fishery,” Graves said, adding that about 2.1 million pounds of claws were harvested last year around Florida. “Probably in four or five years, we’ll be able to start catching three or three-and-a-half million pounds (annually) like we used to.”

Graves said the COVID-19 pandemic has fishermen on edge because most commercially harvested claws are sold to restaurants across Florida.

“Retail, I think, is strong,” Graves said. “We see a lot of people ordering (seafood) online or going to the grocery store and buying and eating at home.

“But we just don’t know what restaurants are going to do this year in Florida, which are the largest consumers of the crab,” he said.

Source Article

Read more

Participants Of The 6th Annual WEGO Health Awards

Take Care New York (TCNY) 2020 is the City’s blueprint for providing every single New Yorker the possibility to reside a healthier life. As an academic, Parente has played a part in the Obamacare fight, providing supportive evaluation of separate proposals by Residence Speaker Paul Ryan and then-Rep. I think I was so floored by the discovery that my acquaintance had died in a state (MA) where we have had mandatory health insurance coverage for a long time.

Rosante is proof that living a balanced, wholesome lifestyle can be exciting and reasonably priced. About Blog – HCITExperts was formed with the coming together of the specialists in the Healthcare and IT fields to deliver planet class services to our consumers with the good quality in delivery and with the capacity in delivering value to our clients.

If we really want to reform health care, in the small time we might have just before our health care bubble bursts, we will want to take sturdy action against health care corruption. Late this afternoon, the California Division of Public Health (CDPH) emailed a cell phone guidance document, entitled “Cell Phones and Health,” to Melody Gutierrez, a reporter for the San Francisco Chronicle who attended our court hearing.

Esposito referred the Telegram to Alan Wolf, the media relations manager for UNC Health Care and UNC REX Healthcare. In most nations, the financing of health care services characteristics a mix of all 5 models, but the precise distribution varies across nations and over time inside nations.

In the United States, primary care physicians have begun to deliver primary care outside of the managed care (insurance coverage-billing) system by means of direct primary care which is a subset of the much more familiar concierge medicine Physicians in this model bill sufferers directly for services, either on a pre-paid month-to-month, quarterly, or annual basis, or bill for every single service in the workplace.…

Read more